These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30213095)

  • 1. Potassium Citrate Supplementation Decreases the Biochemical Markers of Bone Loss in a Group of Osteopenic Women: The Results of a Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Granchi D; Caudarella R; Ripamonti C; Spinnato P; Bazzocchi A; Massa A; Baldini N
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30213095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
    Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
    Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial.
    Shen CL; Chyu MC; Yeh JK; Zhang Y; Pence BC; Felton CK; Brismée JM; Arjmandi BH; Doctolero S; Wang JS
    Osteoporos Int; 2012 May; 23(5):1541-52. PubMed ID: 21766228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.
    Jafarnejad S; Djafarian K; Fazeli MR; Yekaninejad MS; Rostamian A; Keshavarz SA
    J Am Coll Nutr; 2017; 36(7):497-506. PubMed ID: 28628374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial.
    Shen CL; Yang S; Tomison MD; Romero AW; Felton CK; Mo H
    Osteoporos Int; 2018 Apr; 29(4):881-891. PubMed ID: 29330573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary supplementation with collagen hydrolysates on bone metabolism of postmenopausal women with low mineral density.
    Cúneo F; Costa-Paiva L; Pinto-Neto AM; Morais SS; Amaya-Farfan J
    Maturitas; 2010 Mar; 65(3):253-7. PubMed ID: 19892499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POTASSIUM CITRATE DECREASES BONE RESORPTION IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA: A RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL.
    Gregory NS; Kumar R; Stein EM; Alexander E; Christos P; Bockman RS; Rodman JS
    Endocr Pract; 2015 Dec; 21(12):1380-6. PubMed ID: 26401577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial.
    Macdonald HM; Black AJ; Aucott L; Duthie G; Duthie S; Sandison R; Hardcastle AC; Lanham New SA; Fraser WD; Reid DM
    Am J Clin Nutr; 2008 Aug; 88(2):465-74. PubMed ID: 18689384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
    Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
    J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of French maritime pine bark extract (Oligopin®) supplementation on bone remodeling markers in postmenopausal osteopenic women: A randomized clinical trial.
    Panahande SB; Maghbooli Z; Hossein-Nezhad A; Qorbani M; Moeini-Nodeh S; Haghi-Aminjan H; Hosseini S
    Phytother Res; 2019 Apr; 33(4):1233-1240. PubMed ID: 30907034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Vallibhakara SA; Nakpalat K; Sophonsritsuk A; Tantitham C; Vallibhakara O
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Urinary Citrate With Acid-Base Status, Bone Resorption, and Calcium Excretion in Older Men and Women.
    Shea MK; Dawson-Hughes B
    J Clin Endocrinol Metab; 2018 Feb; 103(2):452-459. PubMed ID: 29211866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecalciferol Supplementation Promotes Bone Turnover in Chinese Adults with Vitamin D Deficiency.
    Yao P; Sun L; Xiong Q; Xu X; Li H; Lin X
    J Nutr; 2018 May; 148(5):746-751. PubMed ID: 29897564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women.
    Bristow SM; Gamble GD; Stewart A; Horne L; House ME; Aati O; Mihov B; Horne AM; Reid IR
    Br J Nutr; 2014 Nov; 112(10):1611-20. PubMed ID: 25274192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium Bicarbonate Supplementation Lowers Bone Turnover and Calcium Excretion in Older Men and Women: A Randomized Dose-Finding Trial.
    Dawson-Hughes B; Harris SS; Palermo NJ; Gilhooly CH; Shea MK; Fielding RA; Ceglia L
    J Bone Miner Res; 2015 Nov; 30(11):2103-11. PubMed ID: 25990255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.